- Dose escalation: Critical elements to support informative drug safety profile and initial efficacy
- Selection of the dose for the late-stage development: decisions around monotherapy, combination regimens
- Incorporation of the patient voice, alignment with medical quality measures, considerations around existing treatment options landscape
